All In Biotech

Free tool

FAERS Monitor: Silenor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022036 or its brand name (Silenor, Doxepin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

2,564

Serious

1,560

61% of reports

Hospitalization

637

Death reported

369

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective278
  • pain228
  • insomnia203
  • fatigue192
  • completed suicide189
  • dizziness186
  • fall183
  • toxicity to various agents168
  • anxiety167
  • headache153
  • off label use145
  • pruritus135
  • product use in unapproved indication131
  • memory impairment117
  • nausea117

Reports by year received

View as table
YearReports
200420
200536
200643
200715
200813
200924
201026
201125
201246
201352
201419
201555
2016146
2017152
2018126
2019223
2020191
2021194
2022156
2023169
2024261
2025335
2026237

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,595 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
completed suicideSignal18918.616.33,144
toxicity to various agentsSignal1688.27.11,059
memory impairmentSignal1177.05.9598
insomniaSignal2036.35.5902
anxietySignal1674.84.2508
fallSignal1834.53.9505
product use in unapproved indicationSignal1314.33.7337
dizzinessSignal1863.12.7262
painSignal2283.02.7320
pruritusSignal1352.92.4167
fatigueSignal1922.01.8102
headacheSignal1532.01.778
drug ineffective2781.71.591
off label use1451.41.214
nausea1171.21.04

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.